Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26806
Abstract: Lenalidomide‐containing (R) triplet and quadruplet regimens are the standard of care for multiple myeloma (MM) and have been shown to increase the risk of thrombosis. The association between thromboembolism (TE) and survival in the novel… read more here.
Keywords: survival; multiple myeloma; risk; induction regimen ... See more keywords